TriSalus Life Sciences - 28 Year Stock Price History | TLSI

The latest closing stock price for TriSalus Life Sciences as of June 18, 2025 is 5.38.

  • An investor who bought $1,000 worth of TriSalus Life Sciences stock at the IPO in 1997 would have $-664 today, roughly -1 times their original investment - a -3.96% compound annual growth rate over 27 years.
  • The all-time high TriSalus Life Sciences stock closing price was 25.50 on March 30, 1998.
  • The TriSalus Life Sciences 52-week high stock price is 6.08, which is 13% above the current share price.
  • The TriSalus Life Sciences 52-week low stock price is 3.50, which is 34.9% below the current share price.
  • The average TriSalus Life Sciences stock price for the last 52 weeks is 5.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

TriSalus Life Sciences - 28 Year Stock Price History | TLSI

  • An investor who bought $1,000 worth of TriSalus Life Sciences stock at the IPO in 1997 would have $-664 today, roughly -1 times their original investment - a -3.96% compound annual growth rate over 27 years.
  • The all-time high TriSalus Life Sciences stock closing price was 25.50 on March 30, 1998.
  • The TriSalus Life Sciences 52-week high stock price is 6.08, which is 13% above the current share price.
  • The TriSalus Life Sciences 52-week low stock price is 3.50, which is 34.9% below the current share price.
  • The average TriSalus Life Sciences stock price for the last 52 weeks is 5.05.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$227.2B
Boston Scientific (BSX)$140.7B
Stryker (SYK)$132.3B
EssilorLuxottica (ESLOY)$128.4B
Medtronic (MDT)$105.9B
Lonza Group Ag (LZAGY)$47.4B
Haleon (HLN)$46.2B
ResMed (RMD)$31.3B
Agilent Technologies (A)$29.2B
GE HealthCare Technologies (GEHC)$28.6B
Terumo (TRUMY)$28.2B
Koninklijke Philips (PHG)$22.2B
Zimmer Biomet Holdings (ZBH)$19.4B
Insulet (PODD)$17.3B
Baxter (BAX)$14.8B
Smith & Nephew SNATS (SNN)$11.4B
Sunny Optical Technology (SNPTF)$7.6B
Lantheus Holdings (LNTH)$6.9B
Bio-Rad Laboratories (BIO)$6.7B
Demant (WILYY)$6.6B
Prestige Consumer Healthcare (PBH)$4B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Perrigo (PRGO)$3.5B
ICU Medical (ICUI)$3.4B
Haemonetics (HAE)$2.9B
Envista Holdings (NVST)$2.6B
GN Store Nord (GNNDY)$2.2B
LeMaitre Vascular (LMAT)$1.9B
QuidelOrtho (QDEL)$1.7B
AtriCure (ATRC)$1.6B